Literature DB >> 3063661

Platelet factor 4 (PF4) in septicaemia.

R Lorenz1, M Brauer.   

Abstract

The plasma concentrations of platelet factor 4 were measured in ten patients with septicaemia. In the acute phase the platelet factor 4 values were elevated (27.1 +/- 20.1 ng/ml; mean +/- SD; normal values 4.7 +/- 1.2 ng/ml), and declined significantly after treatment with antibiotics and surgical therapy, respectively (10.6 +/- 7.3 ng/ml; p less than 0.005). The determination of prothrombin time, fibrinopeptide A, AT III and platelet counts demonstrated a coagulation disorder in the acute phase of septicaemia in all patients; a thrombocytopenia (less than 100,000/mm3) was observed in three cases. We suggest that the measurement of platelet factor 4 concentration could be useful as an in vivo indicator and as a follow-up parameter of increased platelet activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063661     DOI: 10.1007/bf01645070

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  [Rapid physiological coagulation method in determination of fibrinogen].

Authors:  A CLAUSS
Journal:  Acta Haematol       Date:  1957-04       Impact factor: 2.195

2.  Changes in the blood coagulation system associated with septicemia.

Authors:  J J Corrigan; W L Ray; N May
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

3.  Hematologic responses induced by endotoxin in normal and endotoxin tolerant dogs.

Authors:  T J MacVittie; R I Walker
Journal:  Exp Hematol       Date:  1980-05       Impact factor: 3.084

4.  Disseminated intravascular coagulation. Findings in 346 patients.

Authors:  J A Spero; J H Lewis; U Hasiba
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

5.  Antithrombin III deficiency in surgical intensive care patients.

Authors:  H G Schipper; J Roos; F vd Meulen; J W ten Cate
Journal:  Thromb Res       Date:  1981 Jan 1-15       Impact factor: 3.944

6.  Observations during the treatment with antithrombin-III concentrate of a case of a tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin.

Authors:  J Jespersen; N R Rasmussen; C Toftgaard
Journal:  Thromb Res       Date:  1982-06-15       Impact factor: 3.944

7.  Effects of bacterial endotoxin and platelet activating factor (PAF) on human platelet aggregation in native whole blood.

Authors:  R B Davis; M F Johnson
Journal:  Thromb Res       Date:  1986-12-01       Impact factor: 3.944

8.  Antithrombin III patterns in disseminated intravascular coagulation.

Authors:  R L Bick; M D Bick; L F Fekete
Journal:  Am J Clin Pathol       Date:  1980-04       Impact factor: 2.493

9.  Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation.

Authors:  P B Neame; J G Kelton; I R Walker; I O Stewart; H L Nossel; J Hirsh
Journal:  Blood       Date:  1980-07       Impact factor: 22.113

10.  Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.

Authors:  J R O'Brien; M D Etherington; M Pashley
Journal:  Thromb Haemost       Date:  1984-07-29       Impact factor: 5.249

View more
  5 in total

1.  Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage.

Authors:  Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2015-10-24       Impact factor: 8.739

2.  Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins.

Authors:  Michael R Yeaman; Nannette Y Yount; Alan J Waring; Kimberly D Gank; Deborah Kupferwasser; Robert Wiese; Arnold S Bayer; William H Welch
Journal:  Biochim Biophys Acta       Date:  2006-11-30

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

4.  Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis.

Authors:  Kandace Gollomp; Amrita Sarkar; Sanjiv Harikumar; Steven H Seeholzer; Gowthami M Arepally; Kristin Hudock; Lubica Rauova; M Anna Kowalska; Mortimer Poncz
Journal:  Blood       Date:  2020-03-05       Impact factor: 25.476

Review 5.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.